BioAI Health, a US-based company involved in the development of AI/SciML-driven predictive testing to improve cancer treatment and outcomes, announces on Wednesday that it has added Jill Stefanelli, PhD as a new member to its advisory board of seasoned industry professionals.

In the new role, Dr Stefanelli will help drive commercial and corporate strategy for the company.

Dr Stefanelli has served as president, board member, and chief business officer at Paige, senior vice president of Partnerships at Invitae and various roles at other global diagnostic companies including Roche Diagnostics and Pacific Biosciences. She has served as senior scientist in the US Department of Agriculture's (USDA) Foreign Animal Disease Laboratory at Plum Island New York.